📰 Jonae Barnes News
Jonae Barnes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jonae Barnes. Real-time updates on events, politics, business and more.
May 22, 2024
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A...
May 22, 2024
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also H
February 28, 2024
Final Results Confirm 98% Sustained Virologic Response Rate at Week 4 Post-Treatment from Lead-in Cohort in Phase 2 HCV Study Enrollment in Phase 3 SUNRISE-3 Study Has Surpassed 1,400 COVID-19...
February 21, 2024
BOSTON, Feb. 21, 2024 -- Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,...
January 3, 2024
BOSTON, Jan. 03, 2024 -- Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,...
November 9, 2023
Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions].
June 5, 2023
05.06.2023 - BOSTON, June 05, 2023 (GLOBE NEWSWIRE) - Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today ...
May 23, 2023
BOSTON, May 23, 2023 -- Atea Pharmaceuticals, Inc. confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding... | May 23, 2023
May 10, 2023
Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Conference Call.
March 3, 2023
Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call.